Inhibitory effect of Rnai on AML1 -ETO fusion gene expression in leukemia cells / 中华血液学杂志
Chinese Journal of Hematology
; (12): 607-610, 2008.
Article
in Zh
| WPRIM
| ID: wpr-239974
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>By inhibiting AML1 -ETO fusion gene expression in Kasumi-1 cells with RNAi, to investigate the changes in cell proliferation and cell cycle.</p><p><b>METHODS</b>The small interference RNAs (siRNAs) specifically targeting the AML1 -ETO fusion gene were synthesized in vitro and transfected into Kasumi-1 cells by electroporation, the non-specific siRNAs transfected cells were taken as control. EGFP plasmid was transfected into Kasumi-1 cell and the transfection efficiency was detected by FCM. Inhibitory effect of siRNAs were detected by real-time RT-PCR and Western blots. Cell proliferation was measured by CCK-8 assay. DNA content was detected by PI assay.</p><p><b>RESULTS</b>The transfection efficiency was 44.5%. The AML1 -ETO specific siRNAs inhibited AML1 -ETO expression at both mRNA and protein levels. The cell proliferation rate in siRNAs treated group was lower than that in control group 72 h after transfection [(47.90 +/- 0.02)% vs (66.90 +/- 0.08)% , P < 0.05]. The cell cycle was blocked at G1 phase 72 h after siRNAs treatment, the cell proportion in G1 phase being 38.3% and 31.6% in control group, while in G2/M phase being 1.8% and 2.4% respectively.</p><p><b>CONCLUSIONS</b>The synthesized siRNAs can inhibit AML1 -ETO fusion gene expression. AML1 -ETO specific siRNA induced the decline of AML1 -ETO fusion protein in Kasumi-1 cell, and then caused the cell cycle blocked in G1 stage and eventually inhibited the cell proliferation.</p>
Full text:
1
Index:
WPRIM
Main subject:
Pathology
/
Transfection
/
Leukemia
/
Oncogene Proteins, Fusion
/
Cell Cycle
/
RNA Interference
/
Cell Line, Tumor
/
Cell Proliferation
/
Core Binding Factor Alpha 2 Subunit
/
RUNX1 Translocation Partner 1 Protein
Limits:
Humans
Language:
Zh
Journal:
Chinese Journal of Hematology
Year:
2008
Type:
Article